Selecting a Subset Based on the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events for Patient-Reported Symptom Monitoring in Lung Cancer Treatment: Mixed Methods Study

被引:8
作者
Veldhuijzen, Evalien [1 ]
Walraven, Iris [2 ]
Belderbos, Jose [1 ]
机构
[1] Netherlands Canc Inst, Dept Radiat Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
[2] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands
来源
JMIR CANCER | 2021年 / 7卷 / 03期
关键词
PRO-CTCAE; lung cancer; side effects; patient-reported outcomes; PROM; symptomatic adverse events; QUALITY-OF-LIFE; CONTENT VALIDITY; CLINICAL-TRIALS; PRO; QUESTIONNAIRE; RELIABILITY; PREVALENCE; DISTRESS; THERAPY; QLQ-C30;
D O I
10.2196/26574
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) item library covers a wide range of symptoms relevant to oncology care. There is a need to select a subset of items relevant to specific patient populations to enable the implementation of PRO-CTCAE-based symptom monitoring in clinical practice. Objective: The aim of this study is to develop a PRO-CTCAE-based subset relevant to patients with lung cancer that can be used for monitoring during multidisciplinary clinical practice. Methods: The PRO-CTCAE-based subset for patients with lung cancer was generated using a mixed methods approach based on the European Organization for Research and Treatment of Cancer guidelines for developing questionnaires, comprising a literature review and semistructured interviews with both patients with lung cancer and health care practitioners (HCPs). Both patients and HCPs were queried on the relevance and impact of all PRO-CTCAE items. The results were summarized, and after a final round of expert review, a selection of clinically relevant items for patients with lung cancer was made. Results: A heterogeneous group of patients with lung cancer (n=25) from different treatment modalities and HCPs (n=22) participated in the study. A final list of eight relevant PRO-CTCAE items was created: decreased appetite, cough, shortness of breath, fatigue, constipation, nausea, sadness, and pain (general). Conclusions: On the basis of the literature and both professional and patient input, a subset of PRO-CTCAE items has been identified for use in patients with lung cancer in clinical practice. Future work is needed to confirm the validity and effectiveness of this PRO-CTCAE-based lung cancer subset internationally and in real-world clinical practice settings.
引用
收藏
页数:12
相关论文
共 50 条
[41]   Dutch translation and linguistic validation of the U.S. National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™) [J].
Evalien Veldhuijzen ;
Iris Walraven ;
Sandra A. Mitchell ;
Elizabeth Yohe Moore ;
Shawn M. McKown ;
Matthew Lauritzen ;
Katherine J. Kim ;
José S. A. Belderbos ;
Neil K. Aaronson .
Journal of Patient-Reported Outcomes, 4
[42]   Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial [J].
Basch, Ethan ;
Pugh, Stephanie L. ;
Dueck, Amylou C. ;
Mitchell, Sandra A. ;
Berk, Lawrence ;
Fogh, Shannon ;
Rogak, Lauren J. ;
Gatewood, Marcha ;
Reeve, Bryce B. ;
Mendoza, Tito R. ;
O'Mara, Ann M. ;
Denicoff, Andrea M. ;
Minasian, Lori M. ;
Bennett, Antonia V. ;
Setser, Ann ;
Schrag, Deborah ;
Roof, Kevin ;
Moore, Joan K. ;
Gergel, Thomas ;
Stephans, Kevin ;
Rimner, Andreas ;
DeNittis, Albert ;
Bruner, Deborah Watkins .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02) :409-418
[43]   Identifying symptomatic adverse events using the patient-reported outcomes version of the common terminology criteria for adverse events in patients with non-small cell lung cancer with epidermal growth factor receptor exon 20 insertion mutations [J].
Zhu, Yanyan ;
Jean-Baptiste, Milenka ;
Lenderking, William R. R. ;
Bell, Jill A. A. ;
Revicki, Dennis A. A. ;
Lin, Huamao M. M. ;
Brake, Rachael ;
Reeve, Bryce B. B. .
CANCER MEDICINE, 2023, 12 (05) :5494-5505
[44]   Implementation of a methodology to assess patient reported outcomes in lung cancer patients: The PeOpLe (Patient-reported Outcomes in Lung cancer) study protocol [J].
Villanueva-Bueno, Cristina ;
Collado-Borrell, Roberto ;
Luis Revuelta-Herrero, Jose ;
Beatriz Fernandez-Roman, Ana ;
Casado-Abad, Gema ;
Escudero-Vilaplana, Vicente .
FARMACIA HOSPITALARIA, 2022, 46 (04) :265-269
[45]   Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and former users of oral selexipag [J].
Stacy Davis ;
Teresa Edwards ;
Lindsey Norcross ;
Sheri Fehnel ;
Amélie Beaudet ;
Marie Eckart ;
John Fastenau .
Journal of Patient-Reported Outcomes, 7
[46]   Feasibility and acceptability of electronic symptom surveillance with clinician feedback using the patient-reported outcomes version of common terminology criteria for adverse events (PRO-CTCAE) in Danish prostate cancer patients [J].
Baeksted C. ;
Pappot H. ;
Nissen A. ;
Hjollund N.H. ;
Mitchell S.A. ;
Basch E. ;
Bidstrup P.E. ;
Dalton S.O. ;
Johansen C. .
Journal of Patient-Reported Outcomes, 1 (1)
[47]   Systematic bias in cancer patient-reported outcomes: symptom 'orphans' and 'champions' [J].
Thomas, Shirley ;
Walsh, Declan ;
Aktas, Aynur .
BMJ SUPPORTIVE & PALLIATIVE CARE, 2019, 9 (01) :67-74
[48]   Patient-Reported Outcomes During Immunotherapy for Metastatic Melanoma: Mixed Methods Study of Patients' and Clinicians' Experiences [J].
Tolstrup, Laerke K. ;
Pappot, Helle ;
Bastholt, Lars ;
Zwisler, Ann-Dorthe ;
Dieperink, Karin B. .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2020, 22 (04)
[49]   Statistical properties of items and summary scores from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE®) in a diverse cancer sample [J].
Mead-Harvey, Carolyn ;
Basch, Ethan ;
Rogak, Lauren J. ;
Langlais, Blake T. ;
Thanarajasingam, Gita ;
Ginos, Brenda F. ;
Lee, Minji K. ;
Yee, Claire ;
Mitchell, Sandra A. ;
Minasian, Lori M. ;
Mendoza, Tito R. ;
Bennett, Antonia, V ;
Schrag, Deborah ;
Dueck, Amylou C. ;
Mazza, Gina L. .
CLINICAL TRIALS, 2025, 22 (02) :161-169
[50]   Benefits of Digital Symptom Monitoring With Patient-Reported Outcomes During Adjuvant Cancer Treatment [J].
Basch, Ethan ;
Leahy, Allison B. ;
Dueck, Amylou C. .
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (07) :701-+